Curcumin improves spatial memory impairment induced by human immunodeficiency virus type 1 glycoprotein 120 V3 loop peptide in rats

Life Sciences

Volumn 85, Issue 1-2, 2009, Pages 1-10

  Tang, Hongmei ^a,b   Lu, Daxiang ^a,b   Pan, Rui ^c   Qin, Xuebin ^d   Xiong, Huangui ^e   Dong, Jun ^a,b  

^a The Key Lab of State Administration of Traditional Chinese Medicine   (China)

^b MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^c JINAN UNIVERSITY   (China)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Curcumin; HAD; HIV 1gp120; Neuroprotection

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CURCUMIN; HUMAN IMMUNODEFICIENCY VIRUS 1 GLYCOPROTEIN GP 120 V3 LOOP PEPTIDE; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DIET SUPPLEMENTATION; DRUG EFFECT; FEMALE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LEARNING DISORDER; LONG TERM POTENTIATION; MALE; MAZE TEST; MEMORY DISORDER; NERVE CELL LESION; NEUROPATHOLOGY; NEUROPROTECTION; NISSL STAINING; NONHUMAN; OXIDATIVE STRESS; RAT; SPATIAL MEMORY;

AIDS DEMENTIA COMPLEX; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CURCUMIN; ELECTROPHYSIOLOGY; EXCITATORY POSTSYNAPTIC POTENTIALS; FEMALE; HIPPOCAMPUS; HIV ENVELOPE PROTEIN GP120; HYDROXYL RADICAL; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENTRICULAR; LIPID PEROXIDATION; LONG-TERM POTENTIATION; MALE; MALONDIALDEHYDE; MAZE LEARNING; MEMORY DISORDERS; NEURONS; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; STEREOTAXIC TECHNIQUES; SUPEROXIDE DISMUTASE;

HUMAN IMMUNODEFICIENCY VIRUS 1; RATTUS;

EID: 67349222186     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.03.013     Document Type: Article

References (65)

1. Adle-Biassette H., Levy Y., Colombel M., Poron F., Natchev S., Keohane C., and Gray F. Neuronal apoptosis in HIV infection in adults. Neuropathology and Applied Neurobiology 21 3 (1995) 218-227
2. Anand P., Sundaram C., Jhurani S., Kunnumakkara A.B., and Aggarwal B.B. Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Letters 267 1 (2008) 133-164
3. Bachis A., Major E.O., and Mocchetti I. Brain-derived neurotrophic factor inhibits human immunodeficiency virus-1/gp120-mediated cerebellar granule cell death by preventing gp120 internalization. The Journal of Neuroscience 23 13 (2003) 5715-5722
4. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., Vescovi A., Bagetta G., Kollias G., Meldolesi J., and Volterra A. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nature Neuroscience 4 7 (2001) 702-710
5. Bliss T.V., and Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361 6407 (1993) 31-39
6. Bolton M.M., Lo D.C., and Sherwood N.T. Long-term regulation of excitatory and inhibitory synaptic transmission in hippocampal cultures by brain-derived neurotrophic factor. Progress in Brain Research 128 (2000) 203-218
7. Bouwman F.H., Skolasky R.L., Hes D., Selnes O.A., Glass J.D., Nance-Sproson T.E., Royal W., Dal Pan G.J., and McArthur J.C. Variable progression of HIV-associated dementia. Neurology 50 6 (1998) 1814-1820
8. Calabrese V., Butterfield D.A., and Stella A.M. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease. The Italian Journal of Biochemistry 52 4 (2003) 177-181
9. Catani M.V., Corasaniti M.T., Navarra M., Nistico G., Finazzi-Agro A., and Melino G. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors. Journal of Neurochemistry 74 6 (2000) 2373-2379
10. Chakrabarti L., Hurtrel M., Maire M.A., Vazeux R., Dormont D., Montagnier L., and Hurtrel B. Early viral replication in the brain of SIV-infected rhesus monkeys. American Journal of Pathology 139 6 (1991) 1273-1280
11. Davis L.E., Hjelle B.L., Miller V.E., Palmer D.L., Llewellyn A.L., Merlin T.L., Young S.A., Mills R.G., Wachsman W., and Wiley C.A. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42 9 (1992) 1736-1739
12. Dettin M., Ferranti P., Scarinci C., Picariello G., and Di Bello C. Is the V3 loop involved in HIV binding to CD4?. Biochemistry 42 30 (2003) 9007-9012
13. Dong J., and Xiong H. Human immunodeficiency virus type 1 gp120 inhibits long-term potentiation via chemokine receptor CXCR4 in rat hippocampal slices. Journal of Neuroscience Research 83 3 (2006) 489-496
14. Dore G.J., Correll P.K., Li Y., Kaldor J.M., Cooper D.A., and Brew B.J. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 13 10 (1999) 1249-1253
15. Dreyer E.B., Kaiser P.K., Offermann J.T., and Lipton S.A. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248 4953 (1990) 364-367
16. Everall I.P., Heaton R.K., Marcotte T.D., Ellis R.J., McCutchan J.A., Atkinson J.H., Grant I., Mallory M., and Masliah E. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathology 9 2 (1999) 209-217
17. Fernandes S.P., Edwards T.M., Ng K.T., and Robinson S.R. HIV-1 protein gp120 rapidly impairs memory in chicks by interrupting the glutamate-glutamine cycle. Neurobiology of Learning and Memory 87 1 (2007) 1-8
18. Fox L., Alford M., Achim C., Mallory M., and Masliah E. Neurodegeneration of somatostatin-immunoreactive neurons in HIV encephalitis. Journal of Neuropathology and Experimental Neurology 56 4 (1997) 360-368
19. Gelbard H.A., James H., Sharer L., Perry S.W., Saito Y., Kazee A.M., Blumberg B.M., and Epstein L.G. Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathology and Applied Neurobiology 21 3 (1995) 208-217
20. Gil L., Martinez G., Gonzalez I., Tarinas A., Alvarez A., Giuliani A., Molina R., Tapanes R., Perez J., and Leon O.S. Contribution to characterization of oxidative stress in HIV/AIDS patients. Pharmacological Research 47 3 (2003) 217-224
21. Glass J.D., Fedor H., Wesselingh S.L., and McArthur J.C. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Annals of Neurology 38 5 (1995) 755-762
22. Glowa J.R., Panlilio L.V., Brenneman D.E., Gozes I., Fridkin M., and Hill J.M. Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist. Brain Research 570 1-2 (1992) 49-53
23. Gupta B., Kulshrestha V.K., Srivastava R.K., and Prasad D.N. Mechanisms of curcumin induced gastric ulcer in rats. The Indian Journal of Medical Research 71 (1980) 806-814
24. Kang H., and Schuman E.M. A requirement for local protein synthesis in neurotrophin-induced hippocampal synaptic plasticity. Science 273 5280 (1996) 1402-1406
25. Kanmogne G.D., Kennedy R.C., and Grammas P. HIV-1 gp120 proteins and gp160 peptides are toxic to brain endothelial cells and neurons: possible pathway for HIV entry into the brain and HIV-associated dementia. Journal of Neuropathology and Experimental Neurology 61 11 (2002) 992-1000
26. Kaul M., and Lipton S.A. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proceedings of the National Academy of Science of the United States of America 96 14 (1999) 8212-8216
27. Kelloff G.J., Crowell J.A., Hawk E.T., Steele V.E., Lubet R.A., Boone C.W., Covey J.M., Doody L.A., Omenn G.S., Greenwald P., Hong W.K., Parkinson D.R., Bagheri D., Baxter G.T., Blunden M., Doeltz M.K., Eisenhauer K.M., Johnson K., Knapp G.G., Longfellow D.G., Malone W.F., Nayfield S.G., Seifried H.E., Swall L.M., and Sigman C.C. Strategy and planning for chemopreventive drug development: clinical development plans II. Journal of Cellular Biochemistry Supplement 26 (1996) 54-71
28. Kovalchuk Y., Hanse E., Kafitz K.W., and Konnerth A. Postsynaptic induction of BDNF-mediated long-term potentiation. Science 295 5560 (2002) 1729-1734
29. Kuttan R., Bhanumathy P., Nirmala K., and George M.C. Potential anticancer activity of turmeric (Curcuma longa). Cancer Letter 29 2 (1985) 197-202
30. Langford T.D., Letendre S.L., Larrea G.J., and Masliah E. Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathology 13 2 (2003) 195-210
31. Manikandan P., Sumitra M., Aishwarya S., Manohar B.M., Lokanadam B., and Puvanakrishnan R. Curcumin modulates free radical quenching in myocardial ischaemia in rats. The International Journal of Biochemistry & Cell Biology 36 10 (2004) 1967-1980
32. Martinez-Serrano A., and Bjorklund A. Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells. The Journal of Neuroscience 16 15 (1996) 4604-4616
33. Masliah E., Ge N., Achim C., Hansen L., and Wiley C. Selective neuronal vulnerability in HIV encephalitis. Journal of Neuropathology and Experimental Neurology 51 6 (1992) 585-593
34. Masliah E., Heaton R.K., Marcotte T.D., Ellis R.J., Wiley C.A., Mallory M., Achim C.L., McCutchan J.A., Nelson J.A., Atkinson J.H., and Grant I. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC group. The HIV Neurobehavioral Research Center. Annals Neurology 42 6 (1997) 963-972
35. Morris R.G., Garrud P., Rawlins J.N., and O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 297 5868 (1982) 681-683
36. Mu J.S., Li W.P., Yao Z.B., and Zhou X.F. Deprivation of endogenous brain-derived neurotrophic factor results in impairment of spatial learning and memory in adult rats. Brain Research 835 2 (1999) 259-265
37. Muller F., Svardal A.M., Aukrust P., Berge R.K., Ueland P.M., and Froland S.S. Elevated plasma concentration of reduced homocysteine in patients with human immunodeficiency virus infection. The American Journal of Clinical Nutrition 63 2 (1996) 242-248
38. Navia B.A., Jordan B.D., and Price R.W. The AIDS dementia complex: I. Clinical features. Annals Neurology 19 6 (1986) 517-524
39. Negi P.S., Jayaprakasha G.K., Jagan Mohan Rao L., and Sakariah K.K. Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture. Journal of Agricultural and Food Chemistry 47 10 (1999) 4297-4300
40. Nosheny R.L., Mocchetti I., and Bachis A. Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration. Neurotoxicity Research 8 1-2 (2005) 187-198
41. Patterson S.L., Abel T., Deuel T.A., Martin K.C., Rose J.C., and Kandel E.R. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 16 6 (1996) 1137-1145
42. Perfettini J.L., Castedo M., Roumier T., Andreau K., Nardacci R., Piacentini M., and Kroemer G. Mechanisms of apoptosis induction by the HIV-1 envelope. Cell Death and Differentiation 12 (2005) 916-923 Suppl
43. Petito C.K., and Roberts B. Evidence of apoptotic cell death in HIV encephalitis. American Journal of Pathology 146 5 (1995) 1121-1130
44. Price R.W., Brew B., Sidtis J., Rosenblum M., Scheck A.C., and Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239 4840 (1988) 586-592
45. Price T.O., Ercal N., Nakaoke R., and Banks W.A. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain Research 1045 1-2 (2005) 57-63
46. Price T.O., Uras F., Banks W.A., and Ercal N. A novel antioxidant N-acetylcysteine amide prevents gp120- and Tat-induced oxidative stress in brain endothelial cells. Experimental Neurology 201 1 (2006) 193-202
47. Pugh C.R., Johnson J.D., Martin D., Rudy J.W., Maier S.F., and Watkins L.R. Human immunodeficiency virus-1 coat protein gp120 impairs contextual fear conditioning: a potential role in AIDS related learning and memory impairments. Brain Research 861 1 (2000) 8-15
48. Reddy A.C., and Lokesh B.R. Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes. Molecular and Cell Biochemistry 111 1-2 (1992) 117-124
49. Sacktor N., Lyles R.H., Skolasky R., Kleeberger C., Selnes O.A., Miller E.N., Becker J.T., Cohen B., and McArthur J.C. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 56 2 (2001) 257-260
50. Sacktor N., McDermott M.P., Marder K., Schifitto G., Selnes O.A., McArthur J.C., Stern Y., Albert S., Palumbo D., Kieburtz K., et al. HIV-associated cognitive impairment before and after the advent of combination therapy. Journal of Neurovirology 8 2 (2002) 136-142
51. Sanchez-Alavez M., Criado J., Gomez-Chavarin M., Jimenez-Anguiano A., Navarro L., Diaz-Ruiz O., Galicia O., Sanchez-Narvaez F., Murillo-Rodriguez E., Henriksen S.J., Elder J.H., and Prospéro-García O. HIV- and FIV-derived gp120 alter spatial memory, LTP, and sleep in rats. Neurobiology Disease 7 4 (2000) 384-394
52. Sandur S.K., Pandey M.K., Sung B., Ahn K.S., Murakami A., Sethi G., Limtrakul P., Badmaev V., and Aggarwal B.B. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 28 8 (2007) 1765-1773
53. Satoskar R.R., Shah S.J., and Shenoy S.G. Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. International Journal of Clinical Pharmacology, Therapy, and Toxicology 24 12 (1986) 651-654
54. Sidhu G.S., Mani H., Gaddipati J.P., Singh A.K., Seth P., Banaudha K.K., Patnaik G.K., and Maheshwari R.K. Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound Repair and Regeneration 7 5 (1999) 362-374
55. Sreejayan, and Rao M.N. Nitric oxide scavenging by curcuminoids. The Journal of Pharmacy and Pharmacology 49 1 (1997) 105-107
56. Sutherland R.J., Kolb B., and Whishaw I.Q. Spatial mapping: definitive disruption by hippocampal or medial frontal cortical damage in the rat. Neuroscience Letter 31 3 (1982) 271-276
57. Thiyagarajan M., and Sharma S.S. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Science 74 8 (2004) 969-985
58. Toda S., Miyase T., Arichi H., Tanizawa H., and Takino Y. Natural antioxidants. III. Antioxidative components isolated from rhizome of Curcuma longa L. Chemical & Pharmaceutical Bulletin 33 4 (1985) 1725-1728
59. Toggas S.M., Masliah E., and Mucke L. Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain Research 706 2 (1996) 303-307
60. Turchan J., Pocernich C.B., Gairola C., Chauhan A., Schifitto G., Butterfield D.A., Buch S., Narayan O., Sinai A., Geiger J., Berger J.R., Elford H., and Nath A. Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology 60 2 (2003) 307-314
61. Vaynman S., Ying Z., and Gomez-Pinilla F. Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. The European Journal of Neuroscience 20 10 (2004) 2580-2590
62. Xiong H., Baskys A., and Wojtowicz J.M. Brain-derived peptides inhibit synaptic transmission via presynaptic GABAB receptors in CA1 area of rat hippocampal slices. Brain Research 737 1-2 (1996) 188-194
63. Xu Y., Ku B., Cui L., Li X., Barish P.A., Foster T.C., and Ogle W.O. Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Research 1162 (2007) 9-18
64. Yang F., Lim G.P., Begum A.N., Ubeda O.J., Simmons M.R., Ambegaokar S.S., Chen P.P., Kayed R., Glabe C.G., Frautschy S.A., and Cole G.M. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. The Journal of Biological Chemistry 280 7 (2005) 5892-5901
65. Zhou M., and Baudry M. Developmental changes in NMDA neurotoxicity reflect developmental changes in subunit composition of NMDA receptors. Journal of Neuroscience 26 11 (2006) 2956-2963